THE PREPARATION AND CHARACTERIZATION OF POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES .3. MICROPARTICLE/POLYMER DEGRADATION RATES AND THE IN-VITRO RELEASE OF A MODEL PROTEIN

被引:102
作者
OHAGAN, DT [1 ]
JEFFERY, H [1 ]
DAVIS, SS [1 ]
机构
[1] UNIV NOTTINGHAM, DEPT PHARMACEUT SCI, NOTTINGHAM NG7 2RD, ENGLAND
关键词
POLY(LACTIDE-CO-GLYCOLIDE); MICROPARTICLES; POLYMER DEGRADATION; CONTROLLED RELEASE VACCINE;
D O I
10.1016/0378-5173(94)90201-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poly(lactide-co-glycolide) (PLG) polymers may be used to entrap antigens for the development of controlled release vaccines, which may be designed to obviate the need for booster doses. Four commercially available PLG polymers (co-polymer compositions and molecular masses: 50:50, 33 kDa; 50:50, 58 kDa; 50:50, 84 kDa and 75:25, 83 kDa) were used to prepare microparticles and their in vitro degradation rates were assessed by three methods: (1) assessment of surface morphology by scanning electron microscopy, (2) weight loss and (3) molecular mass determinations by gel permeation chromatography. Each method confirmed that degradation was more rapid for polymers with a lower molecular mass and a higher glycolide content. Some parameters affecting the rate of release of a model protein (ovalbumin) from microparticles prepared with the polymers were assessed in vitro. The rate of release of the protein was shown to depend on at least three parameters: (1) the molecular mass of the polymer, (2) the co-polymer composition and (3) the protein loading of the microparticles. Generally, the rate of polymer degradation showed good correlation with the rate of protein release and it was shown that the polymers investigated may be appropriate for the development of controlled release vaccines.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 24 条
[1]   VACCINES FOR THE THIRD-WORLD [J].
BLOOM, BR .
NATURE, 1989, 342 (6246) :115-120
[2]   NAFARELIN CONTROLLED RELEASE INJECTABLE - THEORETICAL CLINICAL PLASMA PROFILES FROM MULTIPLE DOSING AND FROM MIXTURES OF MICROSPHERES CONTAINING 2-PERCENT, 4-PERCENT AND 7-PERCENT NAFARELIN [J].
BURNS, RA ;
VITALE, K ;
SANDERS, LM .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :397-413
[3]  
CHALLACOMBE SJ, 1992, IMMUNOLOGY, V76, P164
[4]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[5]  
DUNN RL, 1988, POLYM MED, V3
[6]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[7]   PRACTICE IN DEVELOPING-COUNTRIES [J].
HALL, AJ ;
GREENWOOD, BM ;
WHITTLE, H .
LANCET, 1990, 335 (8692) :774-777
[8]   RELEASE OF HUMAN SERUM-ALBUMIN FROM POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].
HORA, MS ;
RANA, RK ;
NUNBERG, JH ;
TICE, TR ;
GILLEY, RM ;
HUDSON, ME .
PHARMACEUTICAL RESEARCH, 1990, 7 (11) :1190-1194
[9]   CONTROLLED RELEASE OF INTERLEUKIN-2 FROM BIODEGRADABLE MICROSPHERES [J].
HORA, MS ;
RANA, RK ;
NUNBERG, JH ;
TICE, TR ;
GILLEY, RM ;
HUDSON, ME .
BIO-TECHNOLOGY, 1990, 8 (08) :755-758
[10]  
HUTCHINSON FG, 1986, DELIVERY SYSTEMS PEP